3 Ways to Incorporate Adaptive Trials into Your Oncology Drug Development Plans
Add bookmark
3 Ways to Incorporate Adaptive Trials into Your Oncology Drug Development Plans
Add bookmarkThe lengthy clinical development process of drug development for life threatening diseases is not an optimal development strategy for oncology therapeutic area. Adaptive designs have become popular tools in oncology research, helping to achieve validity, efficiency and speed in clinical development. In this interview
Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH, Senior Medical Director, PharmaNet Development Group, Inc., join Andrea Charles from Pharma IQ to discuss optimal design considerations for oncology adaptive clinical trials.
[inlinead]
Tags:
Surya Chitra
Gary Fishbein
PharmaNet Development Group
oncology research
oncology drug development
clinical development
oncology adaptive clinical trials
adaptive clinical trials
clinical development process
oncology therapeutic area
